Sickle cell disease is listed in some research as a cause of focal segmental glomerulosclerosis (FSGS), and APOL1 kidney disease treatments are under research. Here’s a look at FSGS and the APOL1 gene and how they relate to SCD and other conditions.

What have researchers learned about ancestry and the prevalence of cancer-associated genetic alterations? Here’s a look at some recent findings from the AACR Cancer Disparities Progress Report 2022.